四川省已上市中成药标准提取工艺规范化研究--以银翘解毒类制剂为例  

Study on the standardization of the extraction process of Chinese patent medicine in Sichuan province-taking theantidote preparation of Yinqiao as an example

作　　者：唐瑗 王准[2] TANG Yuan;WANG Zhun(Jiangxi University of Traditional Chinese Medicine,Nanchang 330004,Jiangxi;Chengdu University of Traditional Chinese Medicine,Chengdu 611137,Sichuan)

机构地区：[1]江西中医药大学,南昌330004 [2]成都中医药大学,成都611137

出　　处：《中药与临床》2020年第3期61-63,67,共4页Pharmacy and Clinics of Chinese Materia Medica

基　　金：四川省科技计划项目:中成药工艺变更注册法规研究(2017ZR0136)。

摘　　要：文章以四川省已批准上市《中国药典》收载的银翘解毒类制剂为研究对象,通过对该类制剂标准中制法项提取工艺的比较研究,总结归纳四川省已上市中成药标准中提取工艺所存在的不合理问题,基于中医药理论及相关法律规定对中成药标准中提取工艺的规定提出相应建议。This paper takes Yinqiao antidotal preparation which has been approved to be listed in China Pharmacopoeia as the research object.Through the comparative study on the extraction process of preparation method in this kind of preparation standard,the paper summarizes the unreasonable problems existing in the extraction process of Sichuan listed Chinese patent medicine standard.Based on the theory of traditional Chinese medicine and relevant laws and regulations,the paper puts forward corresponding suggestions on the stipulation of extraction process standard of Chinese patent medicine.

关 键 词：银翘解毒类制剂 中成药标准 提取工艺 不合理问题 

分 类 号：G41[文化科学—教育学] R28[文化科学—教育技术学]